dc.contributor.author | Jankovics Péter, | |
dc.contributor.author | Lohner Szilvia, | |
dc.contributor.author | Darcsi, András | |
dc.contributor.author | Németh-Palotás Júlia, | |
dc.contributor.author | Béni, Szabolcs | |
dc.date.accessioned | 2014-11-16T18:03:23Z | |
dc.date.available | 2014-11-16T18:03:23Z | |
dc.date.issued | 2013 | |
dc.identifier | 84871897475 | |
dc.identifier.citation | pagination=83-91; journalVolume=74; journalTitle=JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS; | |
dc.identifier.uri | http://repo.lib.semmelweis.hu//handle/123456789/541 | |
dc.identifier.uri | doi:10.1016/j.jpba.2012.10.013 | |
dc.description.abstract | A new derivative of vardenafil was detected in an alleged herbal dietary supplement and identified as 2-(2-ethoxy-5-(4-(2-hydroxyethyl)piperazin-1-ylsulfonyl)phenyl)-5-methyl-7-propyl-imidazo[1,5-f][1,2,4]triazin-4(3H)-thione. Structure elucidation was carried out by LC–UV–MS/MS and NMR. Results obtained with high resolution MS and IR spectroscopy confirmed the proposed chemical structure. The compound was distinguished from hydroxyvardenafil, a second active substance identified in the same product, by the conversion of the oxo group to a thio group on the imidazo-triazin moiety. Hydroxythiovardenafil was therefore suggested as a proprietary name for the new molecule. This is the first paper to describe a thio-analog of vardenafil in a commercially available product. | |
dc.relation.ispartof | urn:issn:0731-7085 | |
dc.title | Detection and structure elucidation of hydroxythiovardenafil as an adulterant in a herbal dietary supplement | |
dc.type | Journal Article | |
dc.date.updated | 2014-11-16T18:02:41Z | |
dc.language.rfc3066 | en | |
dc.identifier.mtmt | 2159533 | |
dc.identifier.wos | 000314332300012 | |
dc.identifier.pubmed | 23245238 | |
dc.contributor.department | SE/GYTK/Gyógyszerészi Kémiai Intézet | |
dc.contributor.institution | Semmelweis Egyetem |